TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/24 19:47 | 2/8/24 | HLVX | Hillevax, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Hershberg Robert | MA | DO | See Rema | S.d | -173 | 14.93 | 0 | -12 | -1 | 1,128 | D | ||||||||||||||
2/3/23 17:00 | 2/2/23 | ADPT | Adaptive Biotechnologies Corp | WA | Health | BioPrd | Biological Products, (No Diag | Hershberg Robert | WA | D | M.d | 24 | 0.4500 | 0 | 53 | 647 | 61 | D | |||||||||||||||
6/6/22 16:45 | 6/3/22 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Hershberg Robert | CA | D | S | -15 | 22.75 | 0 | -1 | -25 | 2 | D | ||||||||||||||||
4/18/22 20:27 | 4/18/22 | NSTG | Nanostring Technologies Inc | DE | Health | BioPrd | Biological Products, (No Diag | Hershberg Robert | WA | D | M.d | 0 | 0.00 | 0 | 3 | 45 | 11 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |